U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Inactive Ingredients in Approved Drug Products Search

Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with O

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
182970 Q4 2022 OLEYL ALCOHOL TOPICAL CREAM, AUGMENTED 2.00 %w/w Deletion
182971 Q4 2022 OPACODE S-1-8106 BLACK ORAL TABLET, EXTENDED RELEASE NA Deletion
182972 Q4 2022 OPADRY YS-1-10533A ORAL TABLET 8.16 mg Deletion
182973 Q4 2022 OPADRY YS-1-10533A ORAL TABLET, EXTENDED RELEASE 40.00 mg 80mg Deletion
183093 Q4 2022 OLEYL ALCOHOL TOPICAL CREAM 10.00 %w/w MDE Replacement
183094 Q4 2022 OLEYL ALCOHOL TOPICAL CREAM 20mg MDE Replacement
183095 Q3 2022 OPADRY II 31F58914 WHITE ORAL TABLET 23.00 mg MDE Replacement
183096 Q4 2022 OPADRY II 31F58914 WHITE ORAL TABLET 92mg MDE Replacement
183097 Q3 2022 OPADRY II Y-19-7483 CLEAR ORAL CAPSULE, EXTENDED RELEASE 5.74 mg MDE Replacement
183098 Q4 2022 OPADRY II Y-19-7483 CLEAR ORAL CAPSULE, EXTENDED RELEASE 17mg MDE Replacement
183099 Q3 2022 OPADRY OY-52945 YELLOW ORAL TABLET, FILM COATED 11.95 mg MDE Replacement
183100 Q4 2022 OPADRY OY-52945 YELLOW ORAL TABLET, FILM COATED 24mg MDE Replacement
183101 Q3 2022 OPADRY OY-LS-37200 BUFF ORAL TABLET 10.05 mg MDE Replacement
183102 Q4 2022 OPADRY OY-LS-37200 BUFF ORAL TABLET 10mg MDE Replacement
183103 Q3 2022 OPADRY YS-3-7031 CLEAR ORAL TABLET 17.37 mg MDE Replacement
183104 Q4 2022 OPADRY YS-3-7031 CLEAR ORAL TABLET 69mg MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: October 1, 2022
Database Last Updated: October 19, 2022

Back to Top